BioAge Labs
BioAge Labs is a clinical-stage biotechnology company developing novel therapies for obesity and metabolic diseases by leveraging the biology of aging. Their lead program, azelaprag, is an oral drug designed to significantly increase weight loss and improve body composition when used with incretin therapies. The company's research is based on insights from its discovery platform utilizing human longevity data.
Buy Funded Startups lists
Funding Round: Series D
Funding Amount: $170M
Date: 13-Feb-2024
Investors: Sofinnova Investments, Longitude Capital, RA Capital, Cormorant Asset Management, RTW Investments, SV Health Investors, OrbiMed Advisors, Sands Capital, Pivotal bioVenture Partners, Osage University Partners, Lilly Ventures, Amgen Ventures, Andreessen Horowitz
Markets: Biotechnology, Therapeutics, Metabolic Disease, Obesity
HQ: Richmond, California, United States
Founded: 2015
Website: https://bioagelabs.com/
LinkedIn: https://www.linkedin.com/company/bioage-labs
Twitter: https://twitter.com/bioagelabs
Crunchbase: https://www.crunchbase.com/organization/bioage-labs
Leave a Comment
Comments
No comments yet.